We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (152)
- Scheduling (national classification system) (58)
- Manufacturing (31)
- Unique Device Identification (UDI) hub (25)
- Safety monitoring and information (18)
- Compliance and enforcement (16)
- Clinical trials (13)
- Vaping hub (9)
- Legislation (8)
- Advertising (7)
- Shortages and supply disruptions (6)
- Labelling and packaging (5)
- Medicinal cannabis hub (5)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Sunscreens (1)
Search
414 result(s) found, displaying 251 to 275
-
Committee meetingsAdvisory Committee on Medicines (ACM) meeting
-
-
PresentationsTGA presentation slides from Vl all Russia Good Manufacturing Practice (GMP) Conference (22 September 2021).
-
WebinarsThis session will provide information on the creation of UDIs and the role of an Issuing Agency.
-
PresentationsTGA presentation slides from NSW Active MedTech Webinar (8 September 2021).
-
-
-
PresentationsPresentation from TGA Transformation Stakeholder Engagement Forums.
-
PresentationsPresentations from the GMP Forum 2021 have been published.
-
WebinarsAn update on the adoption of the PIC/S Guide to GMP version 14.
-
-
WebinarsExamples of GMP clearance applications common deficiencies.
-
WebinarsCommon validation errors observed in the GMP Clearance section.
-
WebinarsAn introduction of TGA hybrid and remote GMP inspections for domestic and overseas manufacturers.
-
WebinarsA virtual tour around an imaginary sterile facility.
-
WebinarsAn overview of the legislative and GMP requirements of manufacturing of investigational medicinal products and common issues observed in inspections.
-
WebinarsAn overview and update of the Manufacturing Quality Branch on GMP regulatory activities.
-
WebinarsA webinar about legislative and regulatory changes for listed medicine manufacturers and an overview of common issues identified during GMP inspections of listed medicine manufacturers.
-
WebinarsAn update of the impact that COVID-19 has had on the GMP Clearance framework, and a review of the broader implications on global inspection reliance.
-
WebinarsA general overview of contamination control in clean rooms for Biologicals.
-
WebinarsA presentation and Q&A on UDI from a perspective of a global medical technology company.
-
WebinarsCommon deficiencies and FAQs from the GMP inbox.
-
WebinarsAn overview of GMP compliance signals, how we manage these signals for manufacturers of medicines and biologicals and the kind of information that may be required in the assessment of these signals.
-
WebinarsWebinar presentation on regulatory flexibilities and performance during the pandemic.
-